DAVITA INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 126.1 USD | -1.20% |
|
-4.03% | +20.38% |
| Apr. 10 | Davita Announces Dennis Pullin to Its Board of Directors | CI |
| Mar. 13 | Transcript : DaVita Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:00 AM |
Business Summary
- supply of dialysis services (95.3%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2023, services are insured through 2,675 dialysis centers serving nearly 200,800 patients in the United States, and through 367 dialysis centers serving nearly 49,400 patients abroad;
- other (4.7%).
Number of employees: 70,000
Sales per Business
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
U.S. Dialysis
90.1
%
| 10,600 | 91.3 % | 10,937 | 90.1 % | +3.18% |
Other - Ancillary Services
10.7
%
| 1,101 | 9.5 % | 1,299 | 10.7 % | +17.97% |
Elimination of Intersegment Revenues
-0.8
%
| -91 | -0.8 % | -96 | -0.8 % | +5.30% |
Sales per region
| USD in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
94.5
%
| 11,001 | 94.8 % | 11,473 | 94.5 % | +4.29% |
International
6.3
%
| 700 | 6.0 % | 763 | 6.3 % | +9.00% |
Elimination of Intersegment Revenues
-0.8
%
| -91 | -0.8 % | -96 | -0.8 % | +5.49% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 53 | 97-12-31 |
Joel Ackerman
DFI | Director of Finance/CFO | 59 | 17-02-26 |
Jeffrey Giullian
CTO | Chief Tech/Sci/R&D Officer | - | 19-11-30 |
James Hearty
CMP | Compliance Officer | 55 | 18-02-28 |
Alan Cullop
CIO | Chief Investment Officer | - | - |
Nic Eliason
IRC | Investor Relations Contact | - | - |
Jeffrey Wagner
PRN | Corporate Officer/Principal | - | - |
Andrew Mohraz
PRN | Corporate Officer/Principal | - | - |
Bruce Ware
PRN | Corporate Officer/Principal | 48 | - |
| Human Resources Officer | 43 | 19-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
John Nehra
BRD | Director/Board Member | 76 | 00-10-31 |
Barbara Desoer
BRD | Director/Board Member | 71 | 15-10-07 |
Phyllis Yale
BRD | Director/Board Member | 66 | 16-07-10 |
Wendy Schoppert
BRD | Director/Board Member | 57 | 23-07-13 |
Adam Schechter
BRD | Director/Board Member | 59 | 22-09-19 |
Charles Berg
BRD | Director/Board Member | 67 | 07-02-28 |
Javier Rodriguez
CEO | Chief Executive Officer | 53 | 97-12-31 |
Pamela Arway
CHM | Chairman | 70 | 09-04-30 |
Jason Hollar
BRD | Director/Board Member | 51 | 22-05-05 |
Gregory Moore
BRD | Director/Board Member | 59 | 21-09-08 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 87,700,000 | 48,178,534 ( 54.94 %) | 0 | 54.94 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
ROCKWELL MEDICAL, INC. 4.65% | 1,365,000 | 4.65% | 2,265,900 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
DC Healthcare International, Inc. (Washington)
 DC Healthcare International, Inc. (Washington) Medical/Nursing ServicesHealth Services Part of DaVita, Inc., DC Healthcare International, Inc. is an American company that operates kidney dialysis centers. The private company is located in the US. |
Medical/Nursing Services
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
126.1
USD
Average target price
130.6
USD
Spread / Average Target
+3.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +20.38% | 11.06B | |
| -12.12% | 87.46B | |
| +9.72% | 78.56B | |
| +10.85% | 29.37B | |
| -12.25% | 16.78B | |
| -5.06% | 16.01B | |
| -8.68% | 13.98B | |
| +1.87% | 12.31B | |
| -30.35% | 12.07B | |
| -4.03% | 11.4B |
- Stock Market
- Equities
- DVA Stock
- Company DaVita Inc.
